Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here
Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
Pharm-Olam is a clinical research organization (CRO) with global reach and deep expertise in rare disease research. Our...
Tags: Rare & Orphan Disease
Conducting Phase I studies is always complex. At this stage in clinical research, you are examining the tolerability of the...
In a world with COVID-19, remote monitoring is now essential to effectively monitor studies. Sponsors and CROs are either...
Tags: Pharm-Olam Insights, COVID-19
South Africa was once a commonly considered country for inclusion in clinical research, but its popularity caused bottlenecks...
Site Selection is arguably the most critical element to study success. You can have a “perfectly” designed protocol, an...
Tags: Pharm-Olam Insights
Pharm-Olam is a mid-sized, global CRO that provides clinical research solutions with a specialization in allergy and autoimmune
Tags: Allergy & Immunology
In the midst of the COVID-19 pandemic, breathing issues and respiratory conditions are significant concerns. According to the ...
Pharm-Olam was hired to support a Phase 3 study of a monoclonal antibody (mAb) and its impact on patients with...
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
